Vitex Pharma GmbH is a wholesaler of prescription medications (RX), over-the-counter products (OTC), and veterinary medicines. It supplies pharmaceutical companies, pharmacies, and wholesalers with high-quality European pharmaceuticals domestically and internationally.

Vitex Pharma

Vitex Pharmaceuticals | 7,527 followers on LinkedIn. Integrity. Quality. Innovation.  
Your manufacturing partner of choice.  | Vitex Pharmaceuticals is a global leader in the contract manufacture of complementary medicine. 

From our state-of-the-art 26,000sqm best-in-class facility in Sydney, Australia, we are fully equipped to formulate, manufacture and package a wide variety of vitamins, minerals, herbal and nutritional supplements including tablets, softgel capsules, two-piece hardgel capsules and powders.

Vitex is a wholly Australian-owned and family operated company established in 1989.

William Brown

Technical Manager

John B.

Chief Quality Officer at Vitex Pharmaceuticals Pty Ltd

Graham Burgess

Quality Control Director at Vitex Pharmaceuticals

ANDREW HANNA

Vitex Pharmaceuticals

Innovation delivering exceptional results! Vitex was honoured to receive the Innovative Manufacturing Solution Award at last week's CHPA Awards ceremony. The award is testament to the collaboration and teamwork required to deliver a significant improvement in manufacturing efficiencies both in processes and use of materials. The team came together and surpassed their original targets both in outcome and time delivered. Well done team Vitex - this award was well earned by all involved! #vitexpharmaceuticals #integrity #quality #innovation #CHPA #awards #innovation #leaders

🎉✨ Happy Diwali from the Vitex team! ✨🎉 This Diwali, the Vitex team came together to embrace the spirit of the festival—celebrating light, hope, and unity. As we reflect on our journey, we’re grateful for the collaboration and support that make our team truly special. Wishing everyone celebrating a joyful and prosperous Diwali filled with happiness and success! #vitexpharmaceuticals #intergity #quality #innovation #Diwali #TeamCelebration #FestivalOfLights #TogetherWeShine

Vitex is extremely proud to announce our Chairman, Mr Elie Chami, was conferred with the honour of a doctor of letters (honouris causa) for his contributions to the local economy, industry and community. He is now Dr Elie Chami and it is fair to say we are all delighted to share this achievement.

Safety is Everyone's Business! Safety is our priority at Vitex. As we recognise Safety Month during October 2024 our view is that good communication is critical. Keeping an open dialogue on safety not only ensures we are ever vigilant, it supports our culture of excellence in all we do. The team hold regular toolbox talks to discuss safety matters and our Safety Committee do an exceptional job making sure we strive for continual improvement. For more information on October Safety Month go to: https://lnkd.in/gmUjga6j #vitexpharmaceuticals #integrity #quality #innovation #octobersafetymonth #safewayornoway #safetyiseveryonesbusiness

A bright future for Complementary Medicines! Vitex CEO, Dr Aniss Chami, recently attended the launch of the 2024 Industry Snapshot which was held at Parliament House, Canberra. The event was expertly hosted by Complementary Medicines Australia (CMA) and importantly included leaders such as parliamentarians, policy makers and heads of industry. This detailed review considered the current, and future, state of the industry and is the most comprehensive review ever undertaken so promises to be a valuable resource. The event highlighted the value our industry brings to ensure the health and well-being of those that use our products, the jobs we provide and the contribution our industry makes to the local economy. #vitexpharmaceuticals #integrity #quality #innovation #complementarymedicinesaustralia #CMA

Collaboration at its finest! Vitex was delighted to welcome a large contingent of students from UTS last week to its state-of-the-art manufacturing facility at Eastern Creek. The students gained knowledge not only in Manufacturing Process but also Quality Standards and general career advice. It was our absolute pleasure to host such a bright, articulate and curious group of students and we wish them well as some complete their current studies and others embark on their career journey. #vitexpharmaceuticals #integrity #quality #innovation #UTS #careergrowth

Another step forward for WSI and Western Sydney! We’ve announced that Qantas Group and Menzies Aviation will be operating from our brand new purpose built cargo facility. This facility will support thousands of jobs now and into the future - and increase Sydney’s air freight capacity by 33%. 24-hour operations means that local producers can get their goods overseas faster - and businesses like Vitex Pharmaceuticals can ship lifesaving medicines internationally with greater efficiency. Qantas Menzies Aviation #WSI #WesternSydney

Simon Hickey

Good housekeeping = good safety! The Vitex Safety program covers technical aspects but also how we engage with Safety. We view safety as a shared responsibility so each week the team take turns reviewing the site for housekeeping issues. This weekly Housekeeping Blitz ensures our site is maintained in tip top shape at all times, keeps our team safe and helps us in identifying issues and putting corrective actions in place. Safety First and continual improvement are key at Vitex! #vitexpharmaceuticals #integrity #quality #innovation #safetymatters

Metric
Company Name	Vitex Pharma
Symbol
MSH ID	DE:VITEXPHARMA
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Pharmaceuticals
Country	DE
Stage
Employee Count	51
Website	vitexpharma.de
LinkedIn	vitex-pharmaceuticals
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	27.99K
Web Traffic Growth	-0.34
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

VITE

DE:VITEXPHARMA

Vitex Pharma

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue